OPKO Health
OPK
#6172
Rank
A$1.22 B
Marketcap
A$1.59
Share price
-4.27%
Change (1 day)
-45.57%
Change (1 year)

Earnings for OPKO Health (OPK)

Earnings in 2025 (TTM): -A$0.25 Billion

According to OPKO Health 's latest financial reports the company's current earnings are A$0.64 Billion. In 2024 the company made an earning of -A$14.72 Million, an increase over its 2023 earnings that were of -A$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OPKO Health from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.25 Billion1569.22%
2024 -A$14.72 Million-94.38%
2023 -A$0.27 Billion-52.92%
2022 -A$0.56 Billion2691.58%
2021 -A$19.93 Million-128.81%
2020 A$69.14 M-115.96%
2019 -A$0.44 Billion72.03%
2018 -A$0.26 Billion-33.83%
2017 -A$0.39 Billion264.29%
2016 -A$0.11 Billion-46.71%
2015 -A$0.2 Billion-19.31%
2014 -A$0.25 Billion64.11%
2013 -A$0.15 Billion180.06%
2012 -A$52.86 Million53.56%
2011 -A$34.43 Million55.87%
2010 -A$22.09 Million-48.27%
2009 -A$42.69 Million-24.64%
2008 -A$56.65 Million-85.11%
2007 -A$0.39 Billion6.61%
2006 -A$0.36 Billion18539.02%
2005 -A$1.92 Million-32.33%
2004 -A$2.83 Million-45.53%
2003 -A$5.2 Million-64.7%
2002 -A$14.72 Million2.99%
2001 -A$14.29 Million16.9%
2000 -A$12.23 Million104.81%
1999 -A$5.97 Million40.03%
1998 -A$4.27 Million-0%
1997 -A$4.27 Million7.14%
1996 -A$3.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.01 B-20,413.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.55 B-5,202.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.42 B-3,379.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.40 B-5,137.03%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$1.89 B-935.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.18 B-181.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.05 B-1,449.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-A$78.91 Million-65.17%๐Ÿ‡บ๐Ÿ‡ธ USA